AstraZeneca to spend $50 billion in US production build out to avert tariff threat

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the United States by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to President Donald Trump’s tariff policy.
The in… [3861 chars]